Gattex was launched in the U.S. five weeks ago. Nader says short bowel syndrome patients are now receiving drug (he won't say how many patients, exactly) and reimbursement hasn't been a problem so far. Insurance companies are requiring pre-authorization but that was expected, he adds. NPS Pharma is providing financial assistance to patients who cannot afford their insurance co-pay.
-- Reported by Adam Feuerstein in Boston.
Follow Adam Feuerstein on Twitter.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts